J2248 HCPCS code: Injection, micafungin sodium, 1 mg
J2248 is the HCPCS Level II code for injection, micafungin sodium, 1 mg. In 2024 Medicare paid an average of $0.43 per service for J2248 across 465,876 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 300 per day on outpatient hospital claims. Medicare volume rose 64% from 2022 to 2024 (283,996 to 465,876 services). In 2024, about 246 clinicians billed Medicare for J2248 for 261 beneficiaries.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2007-01-01 |
| Last action effective | 2016-01-01 |
Who bills J2248 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 246 |
| Medicare beneficiaries | 261 |
| States with claims | 4 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J2248, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 283,996 | 190 | $0.72 | $0.57 |
| 2023 | 402,503 | 260 | $0.80 | $0.64 |
| 2024 | 465,876 | 261 | $0.55 | $0.43 |
States with the most J2248 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 153,650 | $0.45 |
| Georgia | 77,351 | $0.37 |
| Texas | 74,099 | $0.46 |
| Colorado | 37,210 | $0.41 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 300 | Clinical: Data |
| practitioner claims | 150 | Prescribing Information |
What changed for J2248
- 2007-01-01: J2248 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J2248?
J2248 is the HCPCS Level II code for injection, micafungin sodium, 1 mg. Short descriptor: "Micafungin sodium injection".
How much does Medicare pay for J2248?
In 2024, the average Medicare payment was $0.43 per service (average allowed $0.55).
Does Medicare cover J2248?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J2248 can be billed per day?
300 on outpatient hospital claims; 150 on practitioner claims (NCCI medically unlikely edits).
Related J22 codes
- J2210 — Injection, methylergonovine maleate, up to 0.2 mg
- J2212 — Injection, methylnaltrexone, 0.1 mg
- J2246 — Injection, micafungin in sodium (baxter), not therapeutically equivalent to j2248, 1 mg
- J2247 — Injection, micafungin sodium (par pharm) not thereapeutically equivalent to j2248, 1 mg
- J2249 — Injection, remimazolam, 1 mg
- J2250 — Injection, midazolam hydrochloride, per 1 mg
- J2251 — Injection, midazolam in 0.9% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg
- J2252 — Injection, midazolam in 0.8% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg
- J2253 — Injection, midazolam (seizalam), 1 mg
- J2260 — Injection, milrinone lactate, 5 mg
- J2265 — Injection, minocycline hydrochloride, 1 mg
- J2267 — Injection, mirikizumab-mrkz, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J2248
- Watch J2248 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J2248
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.